Lineage Cell Therapeutics Inc (LCTX)
1.11
+0.01
(+0.91%)
USD |
NYAM |
Apr 25, 16:00
1.15
+0.04
(+3.60%)
After-Hours: 07:13
Lineage Cell Therapeutics Price: 1.11 for April 25, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 25, 2024 | 1.10 | 1.14 | 1.10 | 1.11 | 352938.0 |
| Apr 24, 2024 | 1.15 | 1.15 | 1.10 | 1.10 | 743876.0 |
| Apr 23, 2024 | 1.13 | 1.186 | 1.13 | 1.14 | 333217.0 |
| Apr 22, 2024 | 1.14 | 1.17 | 1.12 | 1.14 | 406686.0 |
| Apr 19, 2024 | 1.22 | 1.23 | 1.12 | 1.15 | 1.099M |
| Apr 18, 2024 | 1.30 | 1.30 | 1.18 | 1.20 | 1.041M |
| Apr 17, 2024 | 1.16 | 1.32 | 1.16 | 1.29 | 2.316M |
| Apr 16, 2024 | 1.24 | 1.27 | 1.15 | 1.15 | 766210.0 |
| Apr 15, 2024 | 1.31 | 1.325 | 1.22 | 1.25 | 678976.0 |
| Apr 12, 2024 | 1.41 | 1.43 | 1.29 | 1.30 | 1.046M |
| Apr 11, 2024 | 1.38 | 1.45 | 1.33 | 1.41 | 857091.0 |
| Apr 10, 2024 | 1.35 | 1.41 | 1.33 | 1.35 | 543031.0 |
| Apr 09, 2024 | 1.47 | 1.47 | 1.335 | 1.40 | 715033.0 |
| Apr 08, 2024 | 1.42 | 1.47 | 1.405 | 1.47 | 935963.0 |
| Apr 05, 2024 | 1.46 | 1.47 | 1.38 | 1.40 | 1.206M |
| Apr 04, 2024 | 1.38 | 1.56 | 1.38 | 1.44 | 1.901M |
| Apr 03, 2024 | 1.40 | 1.415 | 1.32 | 1.36 | 908710.0 |
| Apr 02, 2024 | 1.42 | 1.44 | 1.370 | 1.40 | 752540.0 |
| Apr 01, 2024 | 1.49 | 1.52 | 1.37 | 1.46 | 2.062M |
| Mar 28, 2024 | 1.37 | 1.61 | 1.33 | 1.48 | 4.275M |
| Mar 27, 2024 | 1.28 | 1.47 | 1.28 | 1.40 | 1.329M |
| Mar 26, 2024 | 1.27 | 1.345 | 1.26 | 1.31 | 765434.0 |
| Mar 25, 2024 | 1.25 | 1.29 | 1.24 | 1.28 | 578857.0 |
| Mar 22, 2024 | 1.33 | 1.38 | 1.265 | 1.27 | 649032.0 |
| Mar 21, 2024 | 1.21 | 1.39 | 1.21 | 1.36 | 1.109M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.54
Minimum
Dec 23 2019
3.10
Maximum
Feb 17 2021
1.452
Average
1.31
Median
Feb 06 2020
Price Benchmarks
| Acumen Pharmaceuticals Inc | 3.19 |
| Sarepta Therapeutics Inc | 127.39 |
| CEL-SCI Corp | 1.45 |
| AIM ImmunoTech Inc | 0.4065 |
| IGC Pharma Inc | 0.43 |
Price Related Metrics
| PS Ratio | 21.42 |
| Price to Book Value | 3.300 |
| Earnings Yield | -10.81% |
| Market Cap | 209.27M |